OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Assessment of cerebral spinal fluid biomarkers and microRNA-mediated disease mechanisms in spinal muscular atrophy patient samples
Emily Welby, Rebecca Rehborg, Matthew Harmelink, et al.
Human Molecular Genetics (2021) Vol. 31, Iss. 11, pp. 1830-1843
Closed Access | Times Cited: 13
Emily Welby, Rebecca Rehborg, Matthew Harmelink, et al.
Human Molecular Genetics (2021) Vol. 31, Iss. 11, pp. 1830-1843
Closed Access | Times Cited: 13
Showing 13 citing articles:
Viral mediated knockdown of GATA6 in SMA iPSC ‐derived astrocytes prevents motor neuron loss and microglial activation
Reilly L. Allison, Emily Welby, Guzal Khayrullina, et al.
Glia (2022) Vol. 70, Iss. 5, pp. 989-1004
Open Access | Times Cited: 22
Reilly L. Allison, Emily Welby, Guzal Khayrullina, et al.
Glia (2022) Vol. 70, Iss. 5, pp. 989-1004
Open Access | Times Cited: 22
Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study
Arlene D’Silva, Didu Kariyawasam, Pooja Venkat, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 170-170
Open Access | Times Cited: 13
Arlene D’Silva, Didu Kariyawasam, Pooja Venkat, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 170-170
Open Access | Times Cited: 13
Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy
Marija Babić, Maria Banović, Ivana Berečić, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 5060-5060
Open Access | Times Cited: 13
Marija Babić, Maria Banović, Ivana Berečić, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 5060-5060
Open Access | Times Cited: 13
Treating neuromuscular diseases: unveiling gene therapy breakthroughs and pioneering future applications
Yu‐Fu Wu, Jun‐An Chen, Yuh‐Jyh Jong
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
Yu‐Fu Wu, Jun‐An Chen, Yuh‐Jyh Jong
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
Using Human‐Induced Pluripotent Stem Cell Derived Neurons on Microelectrode Arrays to Model Neurological Disease: A Review
Shiya Lv, Enhui He, Jinping Luo, et al.
Advanced Science (2023) Vol. 10, Iss. 33
Open Access | Times Cited: 9
Shiya Lv, Enhui He, Jinping Luo, et al.
Advanced Science (2023) Vol. 10, Iss. 33
Open Access | Times Cited: 9
Insights into spinal muscular atrophy from molecular biomarkers
Xiaodong Xing, Xinzhu Liu, Xiandeng Li, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 7, pp. 1849-1863
Open Access | Times Cited: 3
Xiaodong Xing, Xinzhu Liu, Xiandeng Li, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 7, pp. 1849-1863
Open Access | Times Cited: 3
Diminished motor neuron activity driven by abnormal astrocytic EAAT1 glutamate transporter activity in spinal muscular atrophy is not fully restored after lentiviral SMN delivery
Emily Welby, Allison D. Ebert
Glia (2023) Vol. 71, Iss. 5, pp. 1311-1332
Open Access | Times Cited: 7
Emily Welby, Allison D. Ebert
Glia (2023) Vol. 71, Iss. 5, pp. 1311-1332
Open Access | Times Cited: 7
Inflammatory markers in cerebrospinal fluid of paediatric spinal muscular atrophy patients receiving nusinersen treatment
Féline E. V. Scheijmans, Inge Cuppen, Maria M Zwartkruis, et al.
European Journal of Paediatric Neurology (2022) Vol. 42, pp. 34-41
Open Access | Times Cited: 11
Féline E. V. Scheijmans, Inge Cuppen, Maria M Zwartkruis, et al.
European Journal of Paediatric Neurology (2022) Vol. 42, pp. 34-41
Open Access | Times Cited: 11
Cerebrospinal fluid characteristics of patients treated with intrathecal nusinersen for spinal muscular atrophy
Rotem Orbach, Liora Sagi, Efraim Sadot, et al.
Muscle & Nerve (2022) Vol. 66, Iss. 6, pp. 762-766
Open Access | Times Cited: 7
Rotem Orbach, Liora Sagi, Efraim Sadot, et al.
Muscle & Nerve (2022) Vol. 66, Iss. 6, pp. 762-766
Open Access | Times Cited: 7
MicroRNAs as Biomarkers in Spinal Muscular Atrophy
Maruša Barbo, Damjan Glavač, Gregor Jezernik, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2428-2428
Open Access | Times Cited: 1
Maruša Barbo, Damjan Glavač, Gregor Jezernik, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2428-2428
Open Access | Times Cited: 1
The Relevance of Spinal Muscular Atrophy Biomarkers in the Treatment Era
Marianna Maretina, V. I. Koroleva, Л. М. Щугарева, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2486-2486
Open Access | Times Cited: 1
Marianna Maretina, V. I. Koroleva, Л. М. Щугарева, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2486-2486
Open Access | Times Cited: 1
IL-1Ra and CCL5, but not IL-10, are promising targets for treating SMA astrocyte-driven pathology
Reilly L. Allison, Mya Suneja, Megan LaCroix, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Reilly L. Allison, Mya Suneja, Megan LaCroix, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Diminished motor neuron activity driven by abnormal astrocytic GLAST glutamate transporter activity in spinal muscular atrophy is not fully restored after lentiviral SMN delivery
Emily Welby, Allison D. Ebert
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Emily Welby, Allison D. Ebert
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
